Supraorbital Nerve Stimulation for Facial Pain.
Chronic facial pain
Intractable facia pain
Neuromodulation of facial pain
Supraorbital nerve stimulation
Trigeminal branch stimulation
Journal
Current pain and headache reports
ISSN: 1534-3081
Titre abrégé: Curr Pain Headache Rep
Pays: United States
ID NLM: 100970666
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
14
04
2023
medline:
22
5
2023
pubmed:
2
5
2023
entrez:
2
5
2023
Statut:
ppublish
Résumé
Chronic facial pain is considered one of the conditions that affect quality of daily life of patients significantly and makes them seek medical help. Intractable facial pain with failed trials of medical treatment and other pain management therapies presents a challenge for neurologists, pain specialists, and neurosurgeons. We describe the possibility of proposing peripheral nerve stimulation of the supraorbital nerves to treat patients with medically intractable facial pain. Stimulation of the supraorbital nerves is performed using percutaneously inserted electrodes that are positioned in the epi-fascial plane, traversing the course of the supraorbital nerves. The procedure has two phases starting with a trial by temporary electrodes that are inserted under fluoroscopic guidance and are anchored to the skin. This trial usually lasts for a few days to 2 weeks. If successful, we proceed to the insertion of a permanent electrode that is tunneled under the skin behind the ear toward the infraclavicular region in which we make a pocket for the implantable pulse generator. This procedure has been used in multiple patients with promising results which was published in literature. Literature shows that it provides relief of medically intractable pain, without the need for destructive procedures or more central modulation approaches with a preferable safety profile compared to other invasive procedures. Supraorbital nerve stimulation is now considered a valid modality of treatment for patients with medically intractable facial pain and can be offered as a reliable alternative for the patients while discussing the proper plan of management.
Identifiants
pubmed: 37129764
doi: 10.1007/s11916-023-01113-6
pii: 10.1007/s11916-023-01113-6
pmc: PMC10198823
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
157-163Informations de copyright
© 2023. The Author(s).
Références
Neuromodulation. 2011 May-Jun;14(3):201-5
pubmed: 21992239
Neurosurg Clin N Am. 2014 Oct;25(4):789-97
pubmed: 25240665
Physiol Rev. 2021 Jan 1;101(1):259-301
pubmed: 32584191
Science. 1967 Jan 6;155(3758):108-9
pubmed: 6015561
Curr Pain Headache Rep. 2016 Dec;20(12):65
pubmed: 27873121
Dis Mon. 2014 Jan;60(1):6-47
pubmed: 24507705
J Clin Neurophysiol. 2019 Nov;36(6):422-429
pubmed: 31688325
Neurology. 2016 Jul 12;87(2):220-8
pubmed: 27306631
Clin Neurol Neurosurg. 2019 Jul;182:112-122
pubmed: 31121470
Brain. 2014 Dec;137(Pt 12):3186-99
pubmed: 25348629
Neuromodulation. 2005 Jan;8(1):7-13
pubmed: 22151378
Pain. 2017 Feb;158(2):261-272
pubmed: 27893485
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
World Neurosurg. 2013 Nov;80(5):642-649.e1
pubmed: 23321375
Curr Pain Headache Rep. 2013 Jan;17(1):307
pubmed: 23247806
Lancet Neurol. 2010 Aug;9(8):807-19
pubmed: 20650402
Neurosurg Focus. 2013 Sep;35(3):E9
pubmed: 23991822
Neurosurg Focus. 2005 May 15;18(5):E3
pubmed: 15913279
Muscle Nerve. 1993 Oct;16(10):997-1008
pubmed: 7692293
Cephalalgia. 2010 May;30(5):599-609
pubmed: 19614702
AJR Am J Roentgenol. 2010 Jun;194(6):1568-74
pubmed: 20489098
Neurophysiol Clin. 2012 Jun;42(4):187-97
pubmed: 22632867
J Neurosurg. 2015 Jul;123(1):283-8
pubmed: 25635476
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Ann Intern Med. 2015 Feb 17;162(4):276-86
pubmed: 25581257